Active Pharma Ingredient Market

Active Pharma Ingredient Market contains market size and forecasts of Active Pharma Ingredient in global, including the following market information:
Global Active Pharma Ingredient Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Active Pharma Ingredient Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Active Pharma Ingredient companies in 2021 (%)
The global Active Pharma Ingredient market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Innovative Active Pharmaceutical Ingredients Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Active Pharma Ingredient include Teva, Novartis, Pfizer, Johnson & Johnson, Mylan, North China Pharmaceutical Group, Dr. Reddy?s Laboratories, Roche and Aurobindo pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Active Pharma Ingredient manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Active Pharma Ingredient Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Active Pharma Ingredient Market Segment Percentages, by Type, 2021 (%)
Innovative Active Pharmaceutical Ingredients
Generic Active Pharmaceutical Ingredients
Global Active Pharma Ingredient Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Active Pharma Ingredient Market Segment Percentages, by Application, 2021 (%)
Oncology
Cardiovascular Disease
Diabetes
Central Nervous System and Neurological Disorders
Endocrinology
Other Therapeutic Applications
Global Active Pharma Ingredient Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Active Pharma Ingredient Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Active Pharma Ingredient revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Active Pharma Ingredient revenues share in global market, 2021 (%)
Key companies Active Pharma Ingredient sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Active Pharma Ingredient sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva
Novartis
Pfizer
Johnson & Johnson
Mylan
North China Pharmaceutical Group
Dr. Reddy?s Laboratories
Roche
Aurobindo pharma
Sun Pharmaceutical Industries
Boehringer Ingelheim GmbH
Bayer
BASF
DSM
Zhejiang Medicine
Biocon
Johnson Matthey
Hisun Pharmacy
Cambrex
Shandong Xinhua Pharmaceutical
Lonza group
Huahai Pharmaceutical
Haerbin Pharmaceutical Group
Cipla
Tian Yao
Lupin
North East Pharmaceutical
Albemarle
Shandong Lukang Pharmaceutical
Jiangsu Hengrui Medicine